GMAB - Johnson & Johnson wins arbitration appeal against Genmab
2024-01-23 07:56:29 ET
More on Genmab, J&J, etc.
- Johnson & Johnson: Is The Dividend Still Safe After The Kenvue Split-Off?
- Johnson & Johnson Remains A Safe Bet Amidst Talc Lawsuits And Ambrx Acquisition
- Genmab: 3 Trends To Track For A Strong 2024 And Beyond
- Johnson & Johnson posts Q4 beat as pharma and MedTech outperform
- Johnson & Johnson beats top and bottom line estimates; reaffirms FY24 outlook